Publications by authors named "Jan Wiegand"

Claim this Profile
N
Nurse-Led Family Support Intervention for Families of Critically Ill Patients: The FICUS Cluster Randomized Clinical Trial.
Rahel Naef, Marie-Madlen Jeitziner, Marco Riguzzi, Stefanie von Felten, Lotte Verweij, Jan Wiegand

JAMA Intern Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of cardiac complications and their impact on outcomes in patients with non-traumatic subarachnoid hemorrhage.
Maarit Lång, Stephan M Jakob, Riikka Takala, Magnus N Lyngbakken, Anu Turpeinen, Jan Wiegand

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia.
Dominik F Draxler, Justine Brodard, Björn Zante, Stephan M Jakob, Jan Wiegand

Thromb J· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of early respiratory support strategies on disease progression in critical COVID-19: a matched subanalysis of the prospective RISC-19-ICU cohort.
Pedro D Wendel Garcia, Hernán Aguirre-Bermeo, Philipp K Buehler, Mario Alfaro-Farias, Bernd Yuen, Jan Wiegand

Crit Care· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indicators of external ventricular drainage-related infections--a retrospective observational study.
Jan Wiegand, Liz Hickson, Tobias M Merz

Acta Neurochir (Wien)· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolically programmed iron chelators.
Raymond J Bergeron, Neelam Bharti, James S McManis, Jan Wiegand

Bioorg Med Chem· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Swiss Monitoring of Potential Organ Donors (SwissPOD): a prospective 12-month cohort study of all adult ICU deaths in Switzerland.
Julius H Weiss, Isabelle Keel, Franz F Immer, Jan Wiegand, Christoph Haberthür

Swiss Med Wkly· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desferrithiocin: a search for clinically effective iron chelators.
Raymond J Bergeron, Jan Wiegand, James S McManis, Neelam Bharti

J Med Chem· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxygen kinetics during 6-minute walk tests in patients with cardiovascular and pulmonary disease.
Lukas Kern, Sophie Condrau, Florent Baty, Jan Wiegand, Arno J R van Gestel

BMC Pulm Med· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left ventricular torsion abnormalities in septic shock and corrective effect of volume loading: a pilot study.
Stefan Bloechlinger, David Berger, Jürg Bryner, Jan Wiegand, Martin W Dünser

Can J Cardiol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemodynamic assessment of critically ill patients using a miniaturized transesophageal echocardiography probe.
Luca Cioccari, Hans-Rudolf Baur, David Berger, Jan Wiegand, Jukka Takala

Crit Care· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse descending necrotizing mediastinitis: surgical therapy and outcome in a single-centre series.
Gregor J Kocher, Beatrix Hoksch, Marco Caversaccio, Jan Wiegand, Ralph A Schmid

Eur J Cardiothorac Surg· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles.
Raymond J Bergeron, Jan Wiegand, Neelam Bharti, James S McManis

J Med Chem· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk assessment in the first fifteen minutes: a prospective cohort study of a simple physiological scoring system in the emergency department.
Tobias M Merz, Reto Etter, Ludger Mende, Daniel Barthelmes, Jan Wiegand

Crit Care· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicity.
Raymond J Bergeron, Jan Wiegand, Neelam Bharti, James S McManis, Shailendra Singh

Biometals· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-minute walk test enhanced by mobile telemetric cardiopulmonary monitoring.
Claudia Tueller, Lukas Kern, Andrea Azzola, Florent Baty, Sophie Condrau, Jan Wiegand

Respiration· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza A(H1N1) infection and severe cardiac dysfunction in adults: A case series.
Jan A Wiegand, Christian Torgersen, Stefan Bloechlinger, Jukka Takala, Martin W Dünser

Wien Klin Wochenschr· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of polyether chain length on the iron clearing efficiency and physiochemical properties of desferrithiocin analogues.
Raymond J Bergeron, Neelam Bharti, Jan Wiegand, James S McManis, Shailendra Singh

J Med Chem· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vibriobactin antibodies: a vaccine strategy.
Raymond J Bergeron, Neelam Bharti, Shailendra Singh, James S McManis, Jan Wiegand

J Med Chem· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desferrithiocin analogue uranium decorporation agents.
Raymond J Bergeron, Jan Wiegand, Shailendra Singh

Int J Radiat Biol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desferrithiocin analogues and nephrotoxicity.
Raymond J Bergeron, Jan Wiegand, James S McManis, Neelam Bharti, Shailendra Singh

J Med Chem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of laughter on air trapping in severe chronic obstructive lung disease.
Martin H Brutsche, Paul Grossman, Rebekka E Müller, Jan Wiegand, Pello

Int J Chron Obstruct Pulmon Dis· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and testing of non-nephrotoxic desazadesferrithiocin polyether analogues.
Raymond J Bergeron, Jan Wiegand, James S McManis, Neelam Bharti, Shailendra Singh

J Med Chem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does a negative D-dimer test rule out aortic dissection?
Jan Wiegand, Michael Koller, Roland Bingisser

Swiss Med Wkly· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the 3,6,9-trioxadecyloxy group on desazadesferrithiocin analogue iron clearance and organ distribution.
Raymond J Bergeron, Jan Wiegand, Neelam Bharti, Shailendra Singh, James R Rocca

J Med Chem· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis